Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
about
Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.SGLT2 Inhibitors: Glucotoxicity and Tumorigenesis Downstream the Renal Proximal Tubule?Association of Increasing GFR with Change in Albuminuria in the General Population.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.
P2860
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@ast
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@en
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@nl
type
label
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@ast
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@en
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@nl
prefLabel
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@ast
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@en
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@nl
P2093
P2860
P356
P1476
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
@en
P2093
Alberto Martínez-Castelao
Javier Nieto
Jose Luis Górriz
Luis M Pallardó
Pablo Molina
P2860
P304
P356
10.3390/JCM4101866
P407
P577
2015-10-23T00:00:00Z